Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
involved in patent litigation with MedImmune Oncology, Inc. concerning this
product in the U.S. District Court for the District of Maryland.
is indicated to reduce the cumulative renal toxicity
associated with repeated administration of cisplatin in patients with
ovarian cancer. This new pr...
Quality of life: most important predictor of survival for advanced NSCLC patients
...tients with locally advanced non-small cell lung cancer enrolled in a treatment trial (Radiation Therapy Oncology Group 9801 assessing the addition of amifostine
to induction chemotherapy followed by concurrent chemoradiation). In addition to quality of life surveys, factors used to predict overall survival, i...
Radioprotective effect of Heat Shock Proteins
...that the results with HSP25 were similar to those observed with amifostine, an FDA-approved radioprotective drug. However, differences did exist: only amifostine
protected all components of salivary fluid from change, but HSP25 afforded better protection from apoptosis than amifostine.
These results demonst...
Amifostine Renders Cancer More Susceptible To Radiation
... The drug amifostine
has been found to ease most of the side affects as...om already published studies to evaluate if adding amifostine
to radiation therapy decreased the occurrence of s...ent recovers. The study also wanted to find out if amifostine
protected the cancer from radiation. The researche...